Assistance Publique des Hôpitaux de Paris SA
🇫🇷France
- Country
- 🇫🇷France
- Ownership
- Private
- Established
- 1849-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.aphp.fr
Resveratrol and Huntington Disease
Not Applicable
Completed
- Conditions
- Huntington Disease
- Interventions
- Dietary Supplement: ResveratrolOther: Placebo
- First Posted Date
- 2015-01-13
- Last Posted Date
- 2020-02-05
- Lead Sponsor
- Assistance Publique - Hôpitaux de Paris
- Target Recruit Count
- 102
- Registration Number
- NCT02336633
- Locations
- 🇫🇷
Institut du Cerveau et de la Moelle, Hôpital de la Pitié Salpêtrière, Paris, France
Azithromycin in Post Diarrheal Haemolytic and Uremic Syndrome
Not Applicable
Completed
- Conditions
- Haemolytic and Uremic Syndrome
- Interventions
- Drug: Placebo (glucose solution 10%)
- First Posted Date
- 2015-01-13
- Last Posted Date
- 2021-10-04
- Lead Sponsor
- Assistance Publique - Hôpitaux de Paris
- Target Recruit Count
- 148
- Registration Number
- NCT02336516
- Locations
- 🇫🇷
Arnaud de Villeneuve Hospital, Montpellier, France
Brain Scintigraphy in Normal Versus Kleine-Levin Syndrome Subjects
Completed
- Conditions
- Healthy SubjectsKleine-Levin Syndrome
- Interventions
- Radiation: Brain scintigraphy with injection of Neurolite® (ECD)
- First Posted Date
- 2015-01-13
- Last Posted Date
- 2015-07-21
- Lead Sponsor
- Assistance Publique - Hôpitaux de Paris
- Target Recruit Count
- 56
- Registration Number
- NCT02337023
- Locations
- 🇫🇷
Groupe Hospitalier Pitié Salpêtrière, Paris, France
Reduced Toxicity Conditioning Prior to Unrelated Cord Cell Transplantation for High Risk Myeloid Malignancies
Phase 2
- Conditions
- Leukemia, Myeloid
- Interventions
- First Posted Date
- 2015-01-07
- Last Posted Date
- 2018-08-13
- Lead Sponsor
- Assistance Publique - Hôpitaux de Paris
- Target Recruit Count
- 31
- Registration Number
- NCT02333838
- Locations
- 🇫🇷
Hôpital de Brabois, Hématologie Clinique et thérapie cellulaire, Vandoeuvre les Nancy, France
Evolution of Albumin on AOA1 Patients Supplemented With Coenzyme Q10
Phase 3
Completed
- Conditions
- Ataxia-oculomotor Apraxia 1
- Interventions
- Dietary Supplement: CoQ10Other: Sanomit Placebo
- First Posted Date
- 2015-01-07
- Last Posted Date
- 2017-11-06
- Lead Sponsor
- Assistance Publique - Hôpitaux de Paris
- Target Recruit Count
- 19
- Registration Number
- NCT02333305
- Locations
- 🇫🇷
ICM Institute, Paris, France
Efficacy of Corticosteroids to Treat Outpatients With Acute Exacerbations of COPD
Phase 4
Completed
- Conditions
- Pulmonary DiseaseChronic Obstructive (MeSH)
- Interventions
- Drug: Placebo
- First Posted Date
- 2015-01-05
- Last Posted Date
- 2024-01-10
- Lead Sponsor
- Assistance Publique - Hôpitaux de Paris
- Target Recruit Count
- 189
- Registration Number
- NCT02330952
- Locations
- 🇫🇷
Assistance Publique - Hopitaux Paris, Paris, France
Tracheal Intubation vs. Bag-valve-mask Ventilation in Patients With Out-of-Hospital Cardiac Arrest _ CAAM STUDY
Not Applicable
Completed
- Conditions
- Out-of-hospital Cardiac Arrest
- Interventions
- Procedure: bag-valve-mask ventilationProcedure: tracheal intubation
- First Posted Date
- 2014-12-30
- Last Posted Date
- 2017-05-10
- Lead Sponsor
- Assistance Publique - Hôpitaux de Paris
- Target Recruit Count
- 2043
- Registration Number
- NCT02327026
- Locations
- 🇫🇷
Avicenne Hospital - Aphp, Bobigny, Ile de France, France
Effect of Miglustat on the Nasal Potential Difference in Patients With Cystic Fibrosis Homozygous for the F508del Mutation
Phase 2
Completed
- Conditions
- Cystic Fibrosis
- Interventions
- Drug: Placebo ; Miglustat
- First Posted Date
- 2014-12-25
- Last Posted Date
- 2018-03-19
- Lead Sponsor
- Assistance Publique - Hôpitaux de Paris
- Target Recruit Count
- 16
- Registration Number
- NCT02325362
- Locations
- 🇫🇷
Assistance publique-Hôpitaux de Paris, Hôpital Cochin, Paris, France
PET/CT Imaging of Angiogenesis in Lung or Head and Neck Cancers Prior or During Chemotherapy With Antiangiogenic Agents
Phase 2
Terminated
- Conditions
- Advanced Head and Neck CarcinomaAdvanced Non-small Cell Lung Carcinoma
- Interventions
- Drug: radiopharmaceutical (Flotegatide (18F) or RGD (68Ga)
- First Posted Date
- 2014-12-25
- Last Posted Date
- 2022-07-19
- Lead Sponsor
- Assistance Publique - Hôpitaux de Paris
- Target Recruit Count
- 1
- Registration Number
- NCT02325349
- Locations
- 🇫🇷
Hôpital Tenon - Assistance Publique-Hôpitaux de Paris, Paris, France
Detection Medication Administration Errors Using Bar-code and RFID Technology (DREAM)
Not Applicable
Withdrawn
- Conditions
- Medication Administered in Error
- Interventions
- Device: BCMA (bar-code-assisted medication administration)
- First Posted Date
- 2014-12-25
- Last Posted Date
- 2018-03-14
- Lead Sponsor
- Assistance Publique - Hôpitaux de Paris
- Registration Number
- NCT02325336
© Copyright 2025. All Rights Reserved by MedPath